4.8 Article

SPRED1, a RAS MAPK pathway inhibitor that causes Legius syndrome, is a tumour suppressor downregulated in paediatric acute myeloblastic leukaemia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Mutational landscape and significance across 12 major cancer types

Cyriac Kandoth et al.

NATURE (2013)

Article Genetics & Heredity

Review and update of SPRED1 mutations causing legius syndrome

Hilde Brems et al.

HUMAN MUTATION (2012)

Letter Hematology

SPRED1 disorder and predisposition to leukemia in children

Eric Pasmant et al.

Article Medicine, General & Internal

Clinical and Mutational Spectrum of Neurofibromatosis Type 1-like Syndrome

Ludwine Messiaen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Genetics & Heredity

SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype

E. Pasmant et al.

JOURNAL OF MEDICAL GENETICS (2009)

Editorial Material Genetics & Heredity

Inherited susceptibility to pediatric acute lymphoblastic leukemia

Ross L. Levine

NATURE GENETICS (2009)

Article Genetics & Heredity

Germline genomic variants associated with childhood acute lymphoblastic leukemia

Lisa R. Trevino et al.

NATURE GENETICS (2009)

Article Oncology

Targeting Ras in myeloid leukemias

Benjamin S. Braun et al.

CLINICAL CANCER RESEARCH (2008)

Review Oncology

Hyperactive Ras in developmental disorders and cancer

Suzanne Schubbert et al.

NATURE REVIEWS CANCER (2007)

Review Biochemistry & Molecular Biology

The VASP-Spred-Sprouty domain puzzle

Karin Bundschu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Immunology

Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness

H Inoue et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)

Article Multidisciplinary Sciences

Spred is a Sprouty-related suppressor of Ras signalling

T Wakioka et al.

NATURE (2001)